Candel Therapeutics appoints Martine Zimmermann, PharmD, to its board
Candel Therapeutics, Inc. said it appointed Martine Zimmermann, PharmD, to its board of directors. The company is a clinical-stage biopharmaceutical focused on multimodal immunotherapies for cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.